AIDS News and Research

RSS

Educational initiative proves successful in identifying and diagnosing fibromyalgia

According to The Johns Hopkins University School of Medicine, the Fibromyalgia Circle of Care Initiative has achieved dramatic success in heightening awareness, diagnosis and best practice treatment of fibromyalgia – a complex and chronic pain disorder that plagues an estimated 10 million Americans.

17 Sep 2009

Discovery of key molecule may yield new therapies for AIDS and cancer

Discovery by Hebrew University of Jerusalem researchers of an additional role for a key molecule in our bodies provides a further step in world-wide efforts to develop genetic regulation aimed at controlling many diseases, including AIDS and various types of cancers.

17 Sep 2009

Funding, health professional shortage could prevent South Africa from reaching 2011 ARV target, Health Minister says

South Africa's shortage of health professionals combined with a budget shortfall of over $130 million for the government's HIV programs could keep the country from reaching its goal of providing 80 percent of the people living with HIV/AIDS in need of treatment with antiretroviral drugs (ARVs) by 2011.

17 Sep 2009

Leading doctors call for climate change action to prevent 'global health catastrophe'

On Wednesday, the British Medical Journal (BMJ) and the Lancet simultaneously published an editorial (available here and here) and an accompanying letter (here and here) from 18 doctor association leaders to highlight the need for action at a December U.N. conference on climate change in Copenhagen, Reuters reports (Doyle, 9/16).

17 Sep 2009

Researchers discover HIV Nef protein's role in cell mobility inhibition

In order to be able to ward off disease pathogens, immune cells must be mobile and be able to establish contact with each other. The working group around Professor Dr. Oliver Fackler in the Virology Department of the Hygiene Institute of the Heidelberg University Hospital has discovered a mechanism in an animal model revealing how HIV, the AIDS pathogen, cripples immune cells: Cell mobility is inhibited by the HIV Nef protein.

17 Sep 2009

Matrix Laboratories receives tentative FDA approval for its NDA

Mylan Inc. today announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its New Drug Application (NDA) for Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets, 600 mg/300 mg/300 mg.

16 Sep 2009

Pros and cons of HIV treatments in developing countries

Palumbo is co-leading a clinical study of anti-HIV medicines in Africa and India for the International Maternal Pediatric Adolescent AIDS Clinical Trials Group (IMPAACT). The randomized trial found that a cohort of 82 HIV-infected children ages 6 to 35 months responded better to treatment with the protease-inhibiting drug lopinavir (LPV/r) than did a cohort of 82 children in the same age group who received the anti-retroviral drug nevirapine (NVP).

16 Sep 2009

Transcendental Meditation aids students diagnosed with ADHD

A panel of physicians and scientists will report on the benefits of a simple meditation practice for aiding students diagnosed with ADHD during a national medical webinar, which will be hosted by the David Lynch Foundation on Wednesday, September 30, 12 noon (ET).

16 Sep 2009

Urgent vaccine requirements for treating epidemic diseases voiced at ECI 2009

As a result of dominant media coverage of new epidemic threats such as swine influenza, other infection risks receive less public attention than they deserve. "We would like to bring to everybody's attention that the infectious diseases with the most severe consequences continue to be old acquaintances such as tuberculosis, HIV/AIDS, malaria and hepatitis C. About six million people worldwide die of these diseases every year," says Professor Dr. Dr. h. c. Stefan H. E. Kaufmann, Director of the Max Planck Institute for Infection Biology in Berlin, at the 2nd European Congress of Immunology ECI 2009.

16 Sep 2009

Cytheris' INSPIRE study data of HIV-infected patients with low CD4 T cell counts announced

Cytheris SA, a clinical stage biopharmaceutical company focused on research and development of new therapies for immune modulation, today announced presentation of data from an interim analysis of CLI-107-06 (INSPIRE), a Phase I/IIa study of HIV-infected patients with low CD4 T cell counts. The patients were treated with a three-injection cycle of the Company’s investigative immune-modulator, recombinant human Interleukin-7 (CYT107).

15 Sep 2009

MSD's ISENTRESS approved by the EU Commission for treating HIV-1 infection in adult patients

Merck Sharp & Dohme Limited (MSD) announced today that ISENTRESS® (raltegravir) has been granted an expanded licence from the European Union Commission (Commission) for use in combination with other antiretroviral (ARV) medicinal products for the treatment of HIV-1 infection in adult patients, including adult patients starting HIV-1 therapy for the first time (treatment-naïve), as well as treatment-experienced adult patients.

15 Sep 2009

Anti-fungal pill found to be effective for treating oral candidiasis

A once-daily medication option for treating the most common mouth infection in HIV/AIDS patients has shown to be just as effective and safe as taking an anti-fungal pill five times a day, according to a Henry Ford Hospital study.

15 Sep 2009

Phase III results of Lauriad presented at the 49th Annual ICAAC

BioAlliance Pharma has attended the 49th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in San Francisco to present results on miconazole Lauriad and anti-integrase inhibitor.

15 Sep 2009

CFAR to host AIDS Vaccine 2010 conferrence

The Global HIV Vaccine Enterprise (the Enterprise) today announced that the Center for AIDS Research at Emory University (CFAR) in Atlanta, Georgia will serve as Local Host of AIDS Vaccine 2010, the largest and most important global scientific conference focused on AIDS vaccine research.

15 Sep 2009

Innovative treatments for bowel dysfunction

Twenty percent of all Albertans are plagued by symptoms of diarrhea, constipation, abdominal pain, bloating, and gas. More than an inconvenience for many, these problems are rarely discussed in public, leaving sufferers feeling isolated. Yet bowel symptoms can be disabling, greatly impairing quality of life.

15 Sep 2009

America’s Affordable Health Choices Act helps breast cancer patients recuperate easily

The Breast Cancer Survivor Coalition for Advancement, Reform and Equity (Because we Care) today praised a House of Representatives committee for adopting an amendment to the “America’s Affordable Health Choices Act” (H.R. 3200) that would remove barriers to care for breast cancer survivors.

15 Sep 2009

NIMH awards Center for AIDS Intervention Research $11.16 million grant

The Medical College of Wisconsin's Center for AIDS Intervention Research (CAIR) received a five-year, $11.16 million grant from the National Institutes of Health's National Institute of Mental Health (NIMH) to continue its HIV prevention research.

15 Sep 2009

BioAlliance announces Phase III results of miconazole Lauriad MBT for treatment of oropharyngeal candidiasis

Strativa Pharmaceuticals, the proprietary products division of Par Pharmaceutical Companies, Inc. (NYSE: PRX), today announced that its development partner BioAlliance Pharma SA presented Phase III study results for miconazole Lauriad(R) mucoadhesive buccal tablets (MBT) that demonstrate noninferiority to clotrimazole troches for oropharyngeal candidiasis (OPC), an opportunistic infection of the mouth and throat.

14 Sep 2009

Also in global health news: Polio in Afghanistan; Goosby interview; water shortages in Mexico City; clean water device

Agence France-Presse examines the re-emergence of polio in Afghanistan, which is one of four countries where the disease is endemic. According to AFP, "Health care, or the lack of it, is one of many problems facing Afghanistan, eight years after a war to topple the extremist Taliban regime and the arrival of billions of dollars in international aid." Although UNICEF recently launched a three-day immunization campaign in the country, the "ongoing Taliban insurgency, virulent in the south -- Helmand, Uruzgan and Kandahar provinces in particular -- has meant many children are not being reached," AFP writes (O'Donnell, 9/14).

14 Sep 2009

Washington Post examines HIV/AIDS rights, responsibilities questions

The Washington Post examines how African countries are "grappling with debates over what rights and duties to give those living with [HIV/AIDS] -- a growing segment of the population that remains largely hidden." The newspaper writes: "Across the continent, lawmakers are considering whether to make criminals of those who infect others with HIV, allow bosses to test workers for the virus, punish women who pass it to their babies and give constitutional protections to those with HIV."

14 Sep 2009

AIDS News and Research

Educational initiative proves successful in identifying and diagnosing fibromyalgia

Discovery of key molecule may yield new therapies for AIDS and cancer

Funding, health professional shortage could prevent South Africa from reaching 2011 ARV target, Health Minister says

Leading doctors call for climate change action to prevent 'global health catastrophe'

Researchers discover HIV Nef protein's role in cell mobility inhibition

Matrix Laboratories receives tentative FDA approval for its NDA

Pros and cons of HIV treatments in developing countries

Transcendental Meditation aids students diagnosed with ADHD

Urgent vaccine requirements for treating epidemic diseases voiced at ECI 2009

Cytheris' INSPIRE study data of HIV-infected patients with low CD4 T cell counts announced

MSD's ISENTRESS approved by the EU Commission for treating HIV-1 infection in adult patients

Anti-fungal pill found to be effective for treating oral candidiasis

Phase III results of Lauriad presented at the 49th Annual ICAAC

CFAR to host AIDS Vaccine 2010 conferrence

Innovative treatments for bowel dysfunction

America’s Affordable Health Choices Act helps breast cancer patients recuperate easily

NIMH awards Center for AIDS Intervention Research $11.16 million grant

BioAlliance announces Phase III results of miconazole Lauriad MBT for treatment of oropharyngeal candidiasis

Also in global health news: Polio in Afghanistan; Goosby interview; water shortages in Mexico City; clean water device

Washington Post examines HIV/AIDS rights, responsibilities questions

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News